Fertility-focused tech is attracting an unprecedented amount of venture capital funding, but startups developing new reproductive treatments and diagnostic tools still feel overlooked, PitchBook reports.
Infertility is a massive issue that affects 15% of reproductive-aged couples worldwide, according to the World Health Organization. Studies show that the use of procedures like in vitro fertilization—where eggs and sperm are combined in a lab—have increased dramatically.
The problem is not new, but only in the past couple of years have VCs really turned their attention to startups that are working to address the issue. Last year, $823.1 million was invested across 90 deals globally, according to PitchBook data—an increase of 273.3% and 109.3%, respectively, over five years. Read more.
